Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Clinical trial NCT07558200 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07558200
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Non-Small Cell Lung Cancer Hepatocellular Carcinoma

Start date: 2026-05-15
Primary completion: 2030-04-23
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.